Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: This is why you theoretically don't need 100M additional shares Mr. Goerner

Sooooooo, is what you are saying essentially - on the surface make like you want to be forthcoming, but really do not provide any kind of info that investors need to make assessments? All the while continue to buy back shares?

Are you sure they haven't been in this mode for quite some time now? Opty

Share
New Message
Please login to post a reply